Comparative efficacy and safety of golimumab, infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis- A bayesian indirect treatment comparison meta-analysis
Abstract
Authors
K. Thorlund E. Druyts S. Eapen E. Mills